- Home
- STRO vs XPL Comparison
STRO vs XPL Comparison
Compare STRO & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- XPL
- Stock Information
- Founded
- STRO 2003
- XPL 1984
- Country
- STRO United States
- XPL United States
- Employees
- STRO N/A
- XPL N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- XPL Precious Metals
- Sector
- STRO Health Care
- XPL Basic Materials
- Exchange
- STRO Nasdaq
- XPL Nasdaq
- Market Cap
- STRO 50.0M
- XPL 46.5M
- IPO Year
- STRO 2018
- XPL N/A
- Fundamental
- Price
- STRO $0.87
- XPL $0.62
- Analyst Decision
- STRO Hold
- XPL Strong Buy
- Analyst Count
- STRO 8
- XPL 2
- Target Price
- STRO $6.14
- XPL $1.60
- AVG Volume (30 Days)
- STRO 2.3M
- XPL 73.6K
- Earning Date
- STRO 05-08-2025
- XPL 05-02-2025
- Dividend Yield
- STRO N/A
- XPL N/A
- EPS Growth
- STRO N/A
- XPL N/A
- EPS
- STRO N/A
- XPL N/A
- Revenue
- STRO $62,043,000.00
- XPL N/A
- Revenue This Year
- STRO N/A
- XPL N/A
- Revenue Next Year
- STRO $1.29
- XPL N/A
- P/E Ratio
- STRO N/A
- XPL N/A
- Revenue Growth
- STRO N/A
- XPL N/A
- 52 Week Low
- STRO $0.52
- XPL $0.54
- 52 Week High
- STRO $5.17
- XPL $0.98
- Technical
- Relative Strength Index (RSI)
- STRO 48.53
- XPL 48.26
- Support Level
- STRO $0.80
- XPL $0.59
- Resistance Level
- STRO $1.11
- XPL $0.66
- Average True Range (ATR)
- STRO 0.18
- XPL 0.02
- MACD
- STRO 0.02
- XPL -0.00
- Stochastic Oscillator
- STRO 41.53
- XPL 41.71
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.